Buckner’s Death Puts New Focus on Lewy Body Dementia—A Relatively Unknown but Surprisingly Prevalent Disease
Stephen Gomperts, MD, PhD, a physician-investigator in the Department of Neurology at Massachusetts General Hospital, explains that LBD is actually an umbrella term for two different diseases—one is dementia with Lewy bodies (LBD) and the other is Parkinson’s disease with dementia, which afflicts about 30% of people with Parkinson’s disease (PD).
This April, the Mass General Research Institute hosted its first-ever “externship,” where BPS teachers could volunteer to be a part of a four-day experience to learn about research at Massachusetts General Hospital and opportunities to get students involved.
Researchers at Massachusetts General Hospital are using advanced brain imaging techniques to learn more about how brain disorders function at a molecular and genetic level.
Researchers from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital has developed a new testing protocol to screen infants, toddlers and young children for autism spectrum disorder (ASD) using eye tracking software. The tool could increase early detection rates and reduce the time and cost of current screening techniques.
Clarivate Analytics’s annual Highly Cited Researchers Report was released earlier this month, and we are pleased to announce that 37 investigators from Massachusetts General Hospital made the list.
A team of researchers at Mass General, in collaboration with a team form the Karolinska Institutet in Sweden, recently identified a pattern of brain inflammation in the brains of fibromyalgia patients that could be the key to diagnosing this elusive disorder.
The Mass General Research Institute is made up of numerous centers, labs and researchers within the Massachusetts General Hospital. We are incredibly grateful to be a part of such a large community of innovative scientists. One of our centers, the Martinos Center for Biomedical Imaging, recently highlighted several of their researchers to support women in […]
Determined collaboration and groundbreaking technology have led to exciting advances in efforts to solve the challenges of brain diseases, researchers from the MassGeneral Institute for Neurodegenerative Diseases(MIND) told patients, families and friends recently. On May 16, 2018, nearly 100 people attended the event at the MIND labs at the Charlestown Navy Yard. MIND’s Visiting Day gathering […]
A Mass General research team is investigating if boosting a specific brain activity during sleep can help treat learning and memory deficits in schizophrenia patients.